Clinical Trial Update: Delayed Dose Collagenase Clostridium Histolyticum (CCH) Protocol for Men With Peyronie's Disease [Phase 4]

View source ↗

Summary

A Phase 4 clinical trial update describes a delayed-dose protocol of collagenase Clostridium histolyticum (CCH) for men with Peyronie's disease, currently recru…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Peyronie Disease

Drugs mentioned

• Collagenase Clostridium Histolyticum (CCH) (collagenase clostridium histolyticum)

Snippet

Sponsor: Charitable Union for the Research and Education of Peyronie's Disease | Conditions: Peyronie Disease | Phase 4 | Status: RECRUITING